Human leukocyte and fibroblast interferon in a combination therapy of dendritic keratitis.
Thirty-eight patients with virologically proven dendritic keratitis were treated using either debridement plus human leukocyte interferon (HLI) or debridement plus human fibroblast interferon (HFI) in a randomized, double-blind study. We administered one drop of HLI or HFI (1 X 10(6) reference units/ml) daily and found no significant difference in the action of either type of interferon.
D004564:Electrocoagulation; D005347:Fibroblasts; D006801:Humans; D007372:Interferons / Q000008:administration & dosage / Q000627:therapeutic use*; D007635:Keratitis, Dendritic / Q000188:drug therapy* / Q000601:surgery; D007962:Leukocytes; D014945:Wound Healing
D007372:Interferons